Quintessence Biosciences Overview

  • Founded
  • 1999
Founded
  • Status
  • Out of Business
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Out of Business

Quintessence Biosciences General Information

Description

Developer of cancer drug discovery platform designed to target the ribonucleic acid in cancer cells and research. The company's platform is based on the EVade Ribonuclease technology which allows engineering of human proteins (ribonucleases) for the treatment of human diseases, enabling doctors to improve the lives of patients.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 3300 Commercial Avenue
  • Madison, WI 53714
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Quintessence Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Out of Business 01-Jun-2017 000.00 Completed Out of Business
9. Later Stage VC 20-Jun-2012 00.000 000.00 Completed Generating Revenue
8. Later Stage VC 01-Jan-2012 00000 00.00 Completed Generating Revenue
7. Later Stage VC 01-Jan-2011 00.000 00.00 Completed Generating Revenue
6. Grant 31-Dec-2009 00.000 00.000 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2009 00.000 Completed Generating Revenue
4. Grant 20-Sep-2008 00000 00.000 Completed Generating Revenue
3. Later Stage VC 27-Feb-2008 00.000 00.000 Completed Generating Revenue
2. Grant 27-Nov-2007 $415K $3.06M Completed Generating Revenue
1. Early Stage VC 09-May-2003 $3.06M $3.06M Completed Startup
To view Quintessence Biosciences’s complete valuation and funding history, request access »

Quintessence Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of cancer drug discovery platform designed to target the ribonucleic acid in cancer cells and research. The co
Drug Discovery
Madison, WI
6 As of 2016
000.00
00000000 00 000.00

000000 0

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo co
0000 000000000
Brisbane, CA
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00

00000000

re magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip
0000 000000000
Cambridge, MA
00 As of 0000
0000
0000 0000-00-00
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Quintessence Biosciences Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Second Genome Venture Capital-Backed Brisbane, CA 00 000.00 00000000000 000.00
00000000000 Venture Capital-Backed Cambridge, MA 00 0000 00000000000 0000
00000000 000000 00 Venture Capital-Backed Baltimore, MD 000 00000 00000000000 00000
0000000000 Formerly VC-backed Menlo Park, CA 000 00000 00000000 00000
00000 000 Formerly VC-backed Cherry Hill, NJ 00 000.00 000000000 000.00
You’re viewing 5 of 9 competitors. Get the full list »

Quintessence Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial